ArticleFrontiers in immunology2011

Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.

Berhane Ghebrehiwet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.